Navigation Links
NTU gene research promises better treatment procedures for children with leukemia
Date:8/14/2014

A research team led by Nanyang Technological University (NTU) scientists have made a key finding which is expected to open up improved treatment possibilities for children suffering from leukaemia.

They found that two in three cases of acute lymphoblastic leukaemia, a type of cancer of the white blood cells, may be caused by mutations in one of the two key genes found in children. These genes are however more prevalent in those with Down syndrome.

This means that scientists can design better tailored treatment protocols, depending on which mutating gene is carried by the patient. Such treatments may include lower doses of anti-cancer drugs thus leading to fewer side effects.

Acute lymphoblastic leukaemia is the most common cancer in children, with 50 to 100 children diagnosed each year in Singapore. This gene discovery is good news for those with Down syndrome and the 20 per cent of children who do not respond well to standard therapy.

Children with Down syndrome have a 20 to 50 fold greater risk of developing this blood cancer. They are also prone to suffer a relapse and have a higher risk of dying from the side effects of therapy.

The discovery, made by an international team led by Professor Dean Nizetic from NTU's Lee Kong Chian School of Medicine, was published in the prestigious academic journal Nature Communications last week.

Prof Nizetic's team of experts in ageing and Down syndrome collaborated with researchers from the Queen Mary University in London and the universities of Geneva and Padua on this study.

"By analysing the DNA sequence of patient samples at different stages of the disease, we identified mutations in two genes that turn normal blood cells into cancer cells," said Prof Nizetic, the senior author of the study.

The research team found that the two genes (RAS and JAK) never mutate together, which makes them ideal biomarkers.

"This could benefit all c
'/>"/>

Contact: Lester Kok
lesterkok@ntu.edu.sg
65-679-06804
Nanyang Technological University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New Irish research sheds light on how aspirin works to reduce cancer deaths
2. Scientists detail urgent research agenda to address chronic disease toll
3. ChanTest Announces a Global Campaign to Share New Findings and Developments in Cystic Fibrosis (CF) Research
4. New Research Finds Mesothelioma Surgery Outcomes Can Be Improved, According to Surviving Mesothelioma
5. Ethane Industry 2014 Development Trends in Global & China Regions in a New Study Available at DeepResearchReports.com
6. Researchers identify tests to diagnose invasive aspergillosis with 100 percent accuracy
7. Global Neuropathy Clinical Trials and Deep Analysis 2014 - Worldwide Market Size, Share, Trend, Forecasts, Growth and Research Report
8. Researchers Unlock Clues to How Ebola Disarms Immune System
9. ASTRO awards $35,500 in individual grants to 43 researchers presenting at the 2014 Annual Meeting
10. Caterers in Canada Industry Market Research Report Now Available from IBISWorld
11. Researchers uncover clues about how the most important TB drug attacks its target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... March 06, 2015 US Sports Football ... Maryland camps – two non-contact specialty camps and one ... by Perfect Performance Training, located at Bowie State University ... developing position specific skills, speed and strength of football ... Salisbury University with Marvin Graves, former quarterback in the ...
(Date:3/6/2015)... Johnson & Johnson and Ethicon were ... 5, 2015 in Superior Court in the State of ... jury of 12 awarded Mrs. Perry $700,000 in actual ... an Ethicon TVT Abbrevo plastic sling for stress urinary ... also awarded $5 million in punitive damages. , According ...
(Date:3/6/2015)... Jvion, the Atlanta-based leader in ... Clostridium Difficile (C Diff) predictive use case for ... case is the latest in a broad compliment ... chronic conditions, and individual illnesses. Using the firm’s ... flags at risk individuals to help support clinician ...
(Date:3/6/2015)... NC (PRWEB) March 06, 2015 In a ... of Polish mesothelioma patients reported that shoulder pain was their ... story on its website. Click here to read it ... Warsaw analyzed the medical records of 49 mesothelioma patients ... them reported that it was shoulder pain that first prompted ...
(Date:3/6/2015)... 2015 FCPX developers have announced ... Studios. , “Pro3rd Hue is a lower 3rd pack with ... Pixel Film Studios. “Blurring the line between professional and armature, ... is a set of 30 customizable lower third presets made ... Hue, FCPX users can complement any design with a clean ...
Breaking Medicine News(10 mins):Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2
... Pressure BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" ... corporate activities, including (1) the receipt of a Phase ... National Institutes of Health ("NIH"), (2) a presentation by ... Public Health on the significant advantages in throughput ...
... Positive Committee Recommendation in European UnionCorporate Highlights:- ... Qutenza(TM) (formerly NGX-4010) for treatment of peripheral ... or in combination with other medicinal products ... by U.S. FDA for PHNUpcoming 2009 Milestones:- ...
... to Spot Punctures SoonerNORCROSS, Ga., March 20 Molnlycke ... and the only major surgical glove company with an ... its line this month that helps clinicians notice punctures ... two polyisoprene surgical gloves already in the line. ...
... 20 JLL Partners, a leading private equity investment ... provider of clinical development services (Nasdaq: PDGI ... tender offer by JLL PharmaNet Holdings, LLC ("Parent"), through ... of the outstanding shares of common stock of PharmaNet. ...
... an across-the-board increase in Californai Medicare supplement insurance plan premiums ... for new ways to maximize healthcare dollars and minimize expenses. ... ... March 20, 2009 -- Anthem Blue Cross implemented an across-the-board ...
... indicates that some aspects of peoples, cognitive skills such ... and detect relationships peak at about the age of ... 27. , "This research suggests that some aspects of age-related ... in their 20s and 30s," said Timothy Salthouse, a University ...
Cached Medicine News:Health News:Pressure BioSciences, Inc. Provides Corporate Update 2Health News:Pressure BioSciences, Inc. Provides Corporate Update 3Health News:Pressure BioSciences, Inc. Provides Corporate Update 4Health News:Pressure BioSciences, Inc. Provides Corporate Update 5Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 2Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 3Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 4Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 5Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 6Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 7Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 8Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 9Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 10Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 11Health News:Biogel Introduces Polyisoprene (PI) Indicator Underglove 2Health News:Biogel Introduces Polyisoprene (PI) Indicator Underglove 3Health News:Biogel Introduces Polyisoprene (PI) Indicator Underglove 4Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 2Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 3Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 4Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 5Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 6Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 7Health News:Seniors Seek to Reduce Healthcare Costs as Anthem Blue Cross Increases Premiums 2Health News:Cognitive decline begins in late 20s, study suggests 2
(Date:3/5/2015)... Corporation (Nasdaq: IRIX ) today reported financial results ... , Revenues were $11.8 million in the fourth ... 11% from $10.6 million in the 2013 fourth quarter. Revenues ... from $38.3 million in 2013. , Gross margin for ... the fourth quarter of the prior year. , Operating ...
(Date:3/5/2015)... March 5, 2015  BioPhotas, Inc., an FDA registered ... patented photo-therapeutic technologies to treat skin, muscle and joint ... Semper Fi Fund to provide BioPhotas, flagship product, the ... pain management solutions.  Commenting on the ... who used the Celluma at the Warrior Hope and ...
(Date:3/5/2015)... 5, 2015   ndd Medical Technologies , a ... employs precise ultrasound technology, announced that its EasyOne Pro® ... the San Antonio Pulmonary Fibrosis Support Group. The clinic ... fibrosis (PF), as well as those suspected of having ... a mere 12 square inches, EasyOne Pro provides accurate ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
... Aethlon Medical, Inc. (OTC Bulletin Board: ... filtration devices to address infectious disease and cancer, ... entitled: " A Platform to Address Bioterrorism." ... at: http://www.aethlonmedical.com/knowledge-center/special-reports/ ...
... 2010 Northwestern Memorial Hospital is one ... will test whether operable lung cancer patients and their ... by hardwiring data systems to reduce medical error and ... trial co-sponsored by the Commission on Cancer and the ...
Cached Medicine Technology:'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 2'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 3'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 4Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 2Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 3
The Ahmed Glaucoma Valve has been successfully demonstrated to work in all types of glaucoma cases, particularly neovascular, congenital and uvietic glaucoma....
Ahmed Glaucoma Valve Flexible Plate ....
... a robust and durable drainage system. Preplaced ... globe. Pressure Ridge Molteno Implants have a ... tissue, acts as a Pressure sensitive biological ... implants allows the surgeon to choose the ...
... Baerveldt Glaucoma Implants feature a low implant ... reduced complications. The single-quadrant insertion is technically ... seton plate to be installed with less ... fenestrations of the Baerveldt implant were designed ...
Medicine Products: